Skip to main content
NCBI home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1995 Mar;79(3):250–256. doi: 10.1136/bjo.79.3.250

Is leprosy blindness avoidable? The effect of disease type, duration, and treatment on eye damage from leprosy in Uganda.

K M Waddell, P R Saunderson
PMCID: PMC505073  PMID: 7703204

Abstract

AIMS--The study was designed to measure the prevalence, range, and severity of eye involvement in leprosy patients; to relate this to disease type, duration, and treatment to identify risk factors; and to provide practical guidelines for programme managers and field staff on the prevention of blindness. METHODS--The visual outcome was assessed in a population based sample of patients in Kasese District, Uganda followed for up to two decades, and related to disease features and treatment. A total of 678 patients responded to an invitation out of 2715 registered since 1973. RESULTS--Low vision was present in 4.4% of people and blindness in 1.3%, with 1.5% and 0.6% respectively being due to leprosy. Some 12.4% of patients had iritis, of whom 33% had visual loss in one or both eyes, 3.7% of patients had lagophthalmos, and 11.7% had lens opacity. For multi-bacillary (PB) cases, the adjusted odds ratios were: for iritis 4.6 (95% CI 2.6-8.2), for lagophthalmos 1.4 (0.6-3.2), and for lens opacity 1.7 (1.0-3.0). Potentially sight threatening (PST) lesions were present in 16.8% of patients (95% CI 14.0-19.6). CONCLUSION--Levels of eye involvement in this study are low compared with many surveys. Visual loss is uncommon and is more often caused by other diseases; in the present era of multidrug therapy (MDT) it is very unlikely to be caused by leprosy. It is more common with advancing age. PST lesions, especially iritis, may occur in both PB and MB cases, even if the diagnosis of leprosy is made early and MDT started immediately; they may occur also after completion of MDT. But eye complications need not proceed to loss of sight if treated promptly, and blindness can be avoided. Training of front line staff is therefore crucial.

Full text

PDF
250

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brandt F., Kampik A., Malla O. K., Pokharel R. P., Wos J. Blindness from cataract formation in leprosy. Dev Ophthalmol. 1983;7:1–12. doi: 10.1159/000407307. [DOI] [PubMed] [Google Scholar]
  2. Courtright P. D. Defining the magnitude of ocular complications from leprosy: problems of methodology. Int J Lepr Other Mycobact Dis. 1988 Dec;56(4):566–573. [PubMed] [Google Scholar]
  3. Emiru V. P. Ocular leprosy in Uganda. Br J Ophthalmol. 1970 Nov;54(11):740–743. doi: 10.1136/bjo.54.11.740. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Espiritu C. G., Gelber R., Ostler H. B. Chronic anterior uveitis in leprosy: an insidious cause of blindness. Br J Ophthalmol. 1991 May;75(5):273–275. doi: 10.1136/bjo.75.5.273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Ffytche T. J. Cataract surgery in the management of the late complications of lepromatous leprosy in South Korea. Br J Ophthalmol. 1981 Apr;65(4):243–248. doi: 10.1136/bjo.65.4.243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Ffytche T. J. Residual sight-threatening lesions in leprosy patients completing multidrug therapy and sulphone monotherapy. Lepr Rev. 1991 Mar;62(1):35–43. doi: 10.5935/0305-7518.19910005. [DOI] [PubMed] [Google Scholar]
  7. Ffytche T. J. Role of iris changes as a cause of blindness in lepromatous leprosy. Br J Ophthalmol. 1981 Apr;65(4):231–239. doi: 10.1136/bjo.65.4.231. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Ffytche T. J. The continuing challenge of ocular leprosy. Br J Ophthalmol. 1991 Feb;75(2):123–124. doi: 10.1136/bjo.75.2.123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hogeweg M., Kiran K. U., Suneetha S. The significance of facial patches and type I reaction for the development of facial nerve damage in leprosy. A retrospective study among 1226 paucibacillary leprosy patients. Lepr Rev. 1991 Jun;62(2):143–149. doi: 10.5935/0305-7518.19910016. [DOI] [PubMed] [Google Scholar]
  10. Karaçorlu M. A., Cakiner T., Saylan T. Corneal sensitivity and correlations between decreased sensitivity and anterior segment pathology in ocular leprosy. Br J Ophthalmol. 1991 Feb;75(2):117–119. doi: 10.1136/bjo.75.2.117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Lamba P. A., Santoshkumar D., Arthanariswaran R. Ocular leprosy - a new perspective. Lepr India. 1983 Jul;55(3):490–494. [PubMed] [Google Scholar]
  12. Lewallen S., Courtright P., Lee H. S. Ocular autonomic dysfunction and intraocular pressure in leprosy. Br J Ophthalmol. 1989 Dec;73(12):946–949. doi: 10.1136/bjo.73.12.946. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Mehra V., Minassian D. C. A rapid method of grading cataract in epidemiological studies and eye surveys. Br J Ophthalmol. 1988 Nov;72(11):801–803. doi: 10.1136/bjo.72.11.801. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Prabhakaran K. Cataract in leprosy: a biochemical approach. Lepr Rev. 1971 Mar;42(1):11–13. doi: 10.5935/0305-7518.19710002. [DOI] [PubMed] [Google Scholar]
  15. Ridley D. S., Jopling W. H. Classification of leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis. 1966 Jul-Sep;34(3):255–273. [PubMed] [Google Scholar]
  16. Shorey P., Krishnan M. M., Dhawan S., Garg B. R. Ocular changes in reactions in leprosy. Lepr Rev. 1989 Jun;60(2):102–108. doi: 10.5935/0305-7518.19890013. [DOI] [PubMed] [Google Scholar]
  17. Suryawanshi N., Richard J. Cataract surgery on leprosy patients. Int J Lepr Other Mycobact Dis. 1988 Jun;56(2):238–242. [PubMed] [Google Scholar]
  18. Ticho U., Sira I. B. Ocular leprosy in Malawi. Clinical and therapeutic survey of 8,325 leprosy patients. Br J Ophthalmol. 1970 Feb;54(2):107–112. doi: 10.1136/bjo.54.2.107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Vettom L., Pritze S. Reliability of skin smear results: experiences with quality control of skin smears in different routine services in leprosy control programmes. Lepr Rev. 1989 Sep;60(3):187–196. doi: 10.5935/0305-7518.19890024. [DOI] [PubMed] [Google Scholar]
  20. Walton R. C., Ball S. F., Joffrion V. C. Glaucoma in Hansen's disease. Br J Ophthalmol. 1991 May;75(5):270–272. doi: 10.1136/bjo.75.5.270. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES